Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-2 of 2 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Effects of cardamom supplementation on anheropometric indices, cardiometabolic status, obesity and diabetes gene expression among obese women with polycystic ovary syndrome
Design:
The double blind randomized clinical trial will be performed on 140 women with polycystic ovary syndrome with a body mass index more than 30.
Settings and conduct:
This study will be performed on 140 women with polycystic ovary syndrome referred to Motazedi Educational and Medical Center- Kermanshah during 12 weeks. The intervention group will receive 3 grams of cardamom supplement daily. Before and after the intervention of food intake, physical activity, as well as blood pressure, biochemical indices, lipid profile, sexual hormones, obesity and diabetes genes will be taken from the participants.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Diagnosis of polycystic ovary syndrome based on Rotterdam criteria in 18- 45-year-old volunteer women with a body mass index more than 30 kg/ m2
Exclusion criteria: pregnancy, lactation, diseases such as autoimmune, gastrointestinal, liver, thyroid and unstable cardiovascular diseases, severe depression, mental and psychological illness, severe respiratory diseases (asthma and chronic bronchitis), consumption of any vitamin and mineral supplements, allergies to cardamom, cardamom tea and cardamom products
Intervention groups:
All participants will be subjected to a weight loss diet, in which case they will lose 500-300 kcal per day of energy required based on the ideal adjusted body weight.
Intervention group: 3 grams of cardamom in three doses of one gram with the main meals to reduce possible gastrointestinal complications
Control group: Plasbo with the same appearance of intervention supplements and the same hours of consumption
Main outcome variables:
Anthropometric and cardio-metabolic indices, obesity and diabetes gene
Study aim:
The effect of anti-inflammatory diets, low carbohydrate portfolio and intermittent fasting on cardiometabolic status and gene expression
Design:
The clinical trial has a control group with randomized and open label on 100 patients with pre-diabetes, which will be used for randomization from the table of random numbers.
Settings and conduct:
In order to carry out the present study, by examining the files of patients referred to the central laboratory of Kermanshah University of Medical Sciences, patients who meet the conditions to enter the study will be invited to the laboratory of the School of Nutritional Sciences and Food Technology
Participants/Inclusion and exclusion criteria:
A total 100 patients with pre-diabetes will be invited according to ADA criteria, aged 18-55 years and BMI ≥25 kg/m2, who consented to participate in the study. Conditions for not including to the study as follow: pregnancy, lactation, suffering from diseases such as autoimmune diseases, thyroid and unstable cardiovascular diseases, diabetes, severe depression (due to the inability to answer the questions) ), mental and mental illnesses, and finally medication use related to the above conditions. patients who refuse to cooperate during the intervention, patients who become unavailable due to migration or any other reason, women who become pregnant during the intervention will be excluded from the study.
Intervention groups:
Participants were randomly divided into 4 groups: 1) calorie restriction (control) (n=25), 2) low carbohydrate portfolio diet group (n=25), 3) intermittent fasting group (n=25) and 4) group anti-inflammatory diet (n=25) will be divided.
Main outcome variables:
Improving glycemic indices and related gene expression including insulin Receptor (INSR), transcription factor 7 like 2 (TCF7L2), PPARG Co-activator 1- α (PGC1-a)